The Wellness Center Pharmacy, Inc., dba Designer Drugs

CLOSEOUT LETTER The Wellness Center Pharmacy, Inc., dba Designer Drugs MARCS-CMS 496523 — February 06, 2019 More Warning Letters Warning Letters About Warning and Close-Out Letters Product: Drugs Recipient: Recipient Name Randal J. Davis Recipient Title President The Wellness Center Pharmacy, Inc., dba Designer Drugs 7304 Jarnigan Road Chattanooga , TN 37421 United States Issuing Office: Center for Drug Evaluation and Research United States Dear Mr. Davis: The U.S. Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our warning letter #2016-NOL-11 dated August 5, 2016. Based on our evaluation, it appears that you have adequately addressed the violations contained in this warning letter. You are expected to take all necessary steps to assure compliance with the Federal Food, Drug, and Cosmetic Act and FDA’s implementing regulations. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ Jose R. Lopez Acting Director, Compliance Branch Office of Pharmaceutical Quality Operations Division II Content current as of: 05/23/2019 Regulated Product(s) Drugs